| (AUD) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 7.70M | 47.14% |
| Operating expense | — | — |
| Net income | -21.43M | 21.33% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RCE.AX returned -10.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -43.1% |
| 1 year | -10.8% |
| 5 years | -50.5% |
| 10 years | +77.9% |
| All-time high | $1.46 (Aug 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RCE.AX would be worth today ›No. Recce Pharmaceuticals Ltd has not paid a dividend in the past 12 months.
Recce Pharmaceuticals Ltd is part of the Healthcare sector.
Recce Pharmaceuticals Ltd has a market cap of 113.13M AUD, based on the latest quote.
